Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gaucher disease
Gaucher disease
With a new No. 1, Avrobio hopes to get investors back on gene therapy bandwagon
Fierce Biotech
Wed, 12/7/22 - 10:00 am
Avrobio
clinical trials
AVR-RD-02
Gaucher disease
FDA Awards Orphan Drug Designation to Prevail's Gene Therapy for Gaucher Disease
BioSpace
Fri, 02/14/20 - 10:47 am
FDA
Prevail Therapeutics
gene therapy
Gaucher disease
Protalix flips its Gaucher drug to Pfizer for $46M in R&D cash
Fierce Biotech
Tue, 10/13/15 - 12:16 pm
Protalix BioTherapeutics
Pfizer
R&D
Gaucher disease
Elelyso
How a tiny cell component grew into Genzyme and 43 other biotechs
Bizjournals.com
Fri, 06/5/15 - 04:32 pm
Genzyme
Sanofi
biotech
Gaucher disease
Protalix Drug in Phase IIa Study for Gaucher Disease
Yahoo/Zacks.com
Fri, 06/20/14 - 11:02 am
Protalix BioTherapeutics
Gaucher disease
PRX-112
Protalix BioTherapeutics Initiates Phase II Study With PRX-112, an Orally-Administered Enzyme Replacement Therapy for the Treatment of Gaucher Disease
Yahoo/Globe Newswire
Wed, 06/18/14 - 09:45 am
PRX-112
Protalix BioTherapeutics
Gaucher disease
Can Protalix Revolutionize This Orphan Disease?
Motley Fool
Tue, 10/15/13 - 05:01 pm
orphan drugs
Protalix BioTherapeutics
Gaucher disease
Vpriv
Shire
Sanofi
Genzyme
Cerezyme
Elelyso
Protalix signs supply deal with Brazilian government for Gaucher disease treatment
Yahoo/AP
Wed, 06/19/13 - 10:31 am
Protalix
Brazil
Gaucher disease
UPLYSO
Sanofi's Orphan Drug Eliglustat Tartrate Successful in 2 Late-Stage Trials
Motley Fool
Sat, 02/16/13 - 11:55 am
Sanofi
orphan drugs
eliglustat tartrate
Gaucher disease
Protalix extends collaboration on Gaucher disease drug; Pfizer will manage new Elelyso trials
Yahoo/AP
Fri, 12/7/12 - 10:38 am
Protalix BioTherapeutics
Pfizer
Gaucher disease
Elelyso
A Home Run Drug in the Holy Land
Motley Fool
Sat, 09/29/12 - 11:48 am
Elelyso
Gaucher disease
Protalix BioTherapeutics
Protalix receives marketing authorization for Elelyso from Israel
Yahoo/Fly on the Wall
Thu, 09/27/12 - 10:27 am
Protalix
Elelyso
Israel
Gaucher disease
Gaucher Disease: The Fight For Market Share
Seeking Alpha
Sun, 07/1/12 - 12:12 pm
Gaucher disease
Why Protalix BioTherapeutics Plunged
Motley Fool
Fri, 06/22/12 - 03:28 pm
Protalix BioTherapeutics
Pfizer
Gaucher disease
Protalix Receives a $25 Million Milestone Payment for U.S. Approval of ELELYSO(TM)
Yahoo
Mon, 06/11/12 - 12:53 pm
Protalix BioTherapeutics
Elelyso
Pfizer
Gaucher disease
Pfizer Should Rise On New Gaucher Drug, Due Out In 2013
Seeking Alpha
Tue, 05/8/12 - 10:53 am
Pfizer
Gaucher disease
GSK
AstraZeneca
Eli Lilly
Shire
Protalix BioTherapeutics
Elelyso
U.S. FDA approves Pfizer/Protalix drug for Gaucher
Reuters
Tue, 05/1/12 - 10:13 pm
Pfizer
Protalix BioTherapeutics
FDA
Gaucher disease
Protalix: What You Need To Know Ahead Of The May 1 PDUFA Date
Seeking Alpha
Wed, 03/21/12 - 10:01 am
FDA
Pfizer
Sanofi
Shire
taliglucerase alfa
Gaucher disease
Protalix BioTherapeutics
Sanofi Starts Late-Stage Trial of Eliglustat for Gaucher Disease
Bloomberg
Thu, 01/26/12 - 11:28 am
eliglustat tartrate
Gaucher disease
Sanofi
FDA Extends Taliglucerase Alfa PDUFA Date to May 1, 2012
Yahoo
Tue, 12/6/11 - 11:35 am
FDA
taliglucerase alfa
Protalix BioTherapeutics
Gaucher disease
Pages
1
2
3
next ›
last »